-
FENC Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Fennec Pharmaceuticals (FENC)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 40.32 mm | 40.32 mm | 40.32 mm | 40.32 mm | 40.32 mm | 40.32 mm |
Cash burn (monthly) | 911.33 k | (no burn) | 1.73 mm | (no burn) | 735.33 k | (no burn) |
Cash used (since last report) | 4.63 mm | n/a | 8.81 mm | n/a | 3.74 mm | n/a |
Cash remaining | 35.69 mm | n/a | 31.51 mm | n/a | 36.58 mm | n/a |
Runway (months of cash) | 39.2 | n/a | 18.2 | n/a | 49.8 | n/a |
13F holders | Current |
---|---|
Total holders | 64 |
Opened positions | 9 |
Closed positions | 9 |
Increased positions | 26 |
Reduced positions | 14 |
13F shares | Current |
---|---|
Total value | 74.33 bn |
Total shares | 18.92 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Southpoint Capital Advisors | 4.08 mm | $20.39 bn |
Essetifin SPA | 3.99 mm | $24.96 mm |
Sonic GP | 2.41 mm | $12.04 bn |
Solas Capital Management | 1.92 mm | $9.62 bn |
DG Capital Management | 1.52 mm | $7.61 bn |
BlackRock | 1.23 mm | $6.15 bn |
Vanguard | 1.05 mm | $5.24 bn |
Harbert Fund Advisors | 466.87 k | $2.33 bn |
STT State Street | 328.26 k | $1.64 bn |
Geode Capital Management | 299.30 k | $1.50 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
28 Feb 25 | Raykov Rosty | Common shares | Grant | Acquire A | No | No | 0 | 2,431 | 0.00 | 78,725 |
28 Feb 25 | Robert Andrade | Common shares | Grant | Acquire A | No | No | 0 | 1,042 | 0.00 | 131,549 |
14 Feb 25 | Rallis Chris A | Common Shares | Sell | Dispose S | No | No | 6.82 | 1,186 | 8.09 k | 53,020 |
14 Feb 25 | Rallis Chris A | Common Shares | Option exercise | Acquire M | No | Yes | 2.51 | 1,992 | 5.00 k | 54,206 |
14 Feb 25 | Rallis Chris A | Common Shares Options | Option exercise | Dispose M | No | Yes | 2.51 | 1,992 | 5.00 k | 182,706 |
5 Feb 25 | Raykov Rosty | Common shares | Sell | Dispose S | No | Yes | 6.66 | 10,000 | 66.60 k | 76,294 |
31 Jan 25 | Robert Andrade | Common shares | Grant | Acquire A | No | No | 0 | 1,042 | 0.00 | 130,507 |